ArticleScientific reports2026
Real-time identification of malignant breast tissue during electrosurgical resection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving complete resection of breast cancer with clear margins remains a significant surgical challenge, particularly for infiltrating subtypes, where re-resection rates of up to 45% have been reported. Consequently, a device capable of providing real-time feedback to surgeons regarding the resected breast tissue holds the potential to significantly improve R0 resection rates. This study represents a further advancement toward intraoperative, real-time classification of breast tissue using optical emission spectroscopy (OES). The objective was to establish the feasibility of OES for distinguishing between normal and pathological breast tissue during electrosurgical incision. Spectra obtained from specimens of 80 patients were analyzed, including 68 patients who underwent breast cancer surgery and 12 patients who underwent risk-reducing or breast reduction surgery. Spectroscopic classification was performed of spectra from tumors with no special type (NST) invasive-lobular carcinoma (ILC) using a machine learning approach based on selected spectral features. The true positive rate reached 91,0% for NST spectra and 78.7% for ILC spectra with true negative rates of 95,2% for NST and 85,4% for ILC. In summary, the current support vector machine (SVM) algorithm demonstrates reliable classification performance for the predominant NST subtype. However, the accuracy of the ILC classification still needs to be improved. Further refinement of the OES-based classification approach is necessary to enhance its reliability across all breast cancer subtypes, particularly the rarer forms, thereby facilitating robust real-time detection during surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.